Favrille
Latest round
- Series C
Last raised
- Apr 2004
Total raised
- $72M
Investors
- 15
About Favrille
Favrille is based in the US and operates as a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system.
Who invested in Favrille
15 investors across 3 rounds
See all investors in Favrille
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Favrille
Who invested in Favrille?
Favrille has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Favrille raised?
Favrille has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Favrille last raise money?
Favrille's most recent round on record is a Series C, in Apr 2004.
What does Favrille do?
Favrille is based in the US and operates as a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system.
Where is Favrille headquartered?
Favrille is headquartered in San Diego, US.
Which VCs invest in companies like Favrille?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Favrille's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Favrille? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.